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We describe a case of Cryptosporidium muris infection in an
HIV-infected adult with diarrhea in Kenya. Sequence analysis
of an 840-bp region of the 18S rRNA gene locus demonstrated
the isolate had 100% nucleotide identity with C. muris recov-
ered from a rock hyrax, 98.8% with a C. muris “calf” isolate,
95.5% with C. serpentis, but only 87.8% with C. parvum
“human” type.
yzzer identified the first Cryptosporidium species, C.
muris, in the gastric glands of mice (1). Thereafter, he
identified  C. parvum, which infects the small intestines of
many mammals, and described the complete coccidian life
cycle. Over the next 70 years, more than 23 different species
of the genus were described on the basis of their morphology
and natural hosts. However, when animals were experimen-
tally infected, many of the described Cryptosporidium species
were found to be identical. In the 1970s the classification was
revised, and today only six to eight species are recognized as
valid, with most human, zoonotic, and mammalian infections
being attributed to the different C. parvum genotypes (2,3). C.
muris, which is naturally a murine parasite, appears to have a
more limited host range than C. parvum. Experimental trans-
mission studies of C. muris have shown that the isolate from
laboratory mice can infect other animals, including dogs,
guinea pigs, rabbits, lambs, and gerbils, although it did not
produce patent infections (4). The parasite has also been iso-
lated from a rock hyrax (Procavia sp.) from a zoo and a Bac-
trian camel with chronic cryptosporidiosis (3,5). For many
years, the parasite was thought to infect cattle; however, recent
studies have shown that the C. muris that infects cattle is
genetically distinct, and a new species name, C. andersoni, has
been suggested (6).
Conventional diagnostic methods for Cryptosporidium do
not differentiate the various species and genotypes, and most
infections are diagnosed as C. parvum. C. parvum “human”
and “bovine” genotypes remain the main causes of human
cryptosporidiosis, but lately identification of infections with
other genotypes and also Cryptosporidium species other than
C. parvum has increased in both immunosuppressed and
immunocompetent persons (7-10). Possible asymptomatic
human infection with C. muris was reported in two healthy
girls in Indonesia (11). Morphologic studies on the oocysts
showed they were most likely to be C. muris, although there
was no genotypic or experimental animal confirmation. Phylo-
genetic analysis has enabled more conclusive assignment to
species and genotypes infecting humans and other animals
(12,13). We report a case of C. muris infection, confirmed by
morphology and genotyping, in an adult HIV-infected man
from Kenya, hospitalized with diarrhea.
The Study
Fecal samples were collected from diarrheal patients from
a hospital in Nairobi, Kenya, as part of a larger study. The
patient described was an HIV-infected man who had clinical
tuberculosis and diarrhea. Isospora belli was also detected in a
fecal sample from the patient. 
The fecal samples were preserved in both sodium acetate
formalin and 2.5% potassium dichromate and kept at 4°C.
They were stained with Kinyoun’s carbol fuchsin modified
acid-fast stain and examined by oil immersion microscopy. An
aliquot of 400 µL of the sample suspension in 2.5% potassium
dichromate was processed for genotypic analysis. Potassium
dichromate was washed 5 times with cold, distilled water until
the yellow color cleared. Oocysts were ruptured by freeze-
thaw, and DNA was extracted by using a QIAamp DNA Mini
Kit (Qiagen, West Sussex, UK) for stool DNA purification as
per protocol. 
A section of the SSU (18S) rRNA gene was amplified by
nested polymerase chain reaction (PCR) as described (14),
using the forward primers 5'-TTCTAGAGCTAATACATGCG-
3' and the reverse primer 5'-CCCTAATCCTTCGAAACAGGA-
3' for primary PCR. Secondary PCR used primers 5'-
GGAAGGGTTGTATTTATTAGATAAAG-3' and reverse primer
5'-AAGGAGTAAGGAACAACCTCCA-3', employing the Tec-
hne (FTGENE2D Techne, Cambridge Ltd., UK) thermal cycler.
Restriction fragment analysis of the secondary PCR product was
done by digesting 15 µL of product in a 40-mL total reaction
volume consisting of 15 U of Ssp1 and 3 µL of restriction buffer
(Boehringer Mannheim Biochemicals, Indianapolis, IN) for spe-
cies identification and Asn1 (Boehringer Mannheim) for geno-
typing in the same concentration at 37°C for 1 hour. Digestion
products were separated on 2% agarose gel and visualized by
ethidium bromide staining. The internal (secondary) fragment
was purified by using the Prep-A-Gene DNA purification kit
and cloned into PGEM-T Easy plasmid vector (Promega Cor-
poration, Madison, WI) as described by the manufacturer. The
cloned product was sequenced and aligned with previously
published sequences of the 18S rRNA gene of Cryptosporid-
ium species by using the CLUSTALX (EMBL, Heidelberg,
Germany) program and manual adjustments. Multiple align-
ment was done with the Phylogeny Inference Package
(PHYLIP version 3.5c, J. Felsenstein and the University of
Washington, Seattle, WA). Sequences were analyzed by using
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DNADIST followed by neighbor joining (NEIGHBOR,
PHYLIP package). One hundred replica samplings were ana-
lyzed for percentage bootstrap values. Accession numbers for
Cryptosporidium  18S rRNA genes used were AF093498,
AF093497, AF093496, AF108866 and AF093489, AF093499,
AF112569 AF115377. 
Results 
Microscopic examination of the acid-fast stained fecal
smear revealed ovoid oocysts that were an average size of 7.5-
9.8 x 5.5-7.0 µm (Figure 1). Cysts of I. belli were also identi-
fied in the stained smear.
Restriction endonuclease digestion with Ssp1 of the sec-
ondary PCR 18S rRNA product yielded two fragments of 385
bp and 448 bp in size, while Asn1 digestion yielded two visible
bands that were 102 bp and 731 bp. The results match restric-
tion fragment patterns observed following similar digestions
of C. muris amplicons from rock hyrax and Bactrian camel
isolates (14). 
The resulting sequence 18S r RNA gene fragment of the C.
muris human isolate was deposited in the EMBL Nucleotide
Sequence Database (Accession no. AJ307669). Sequence
analysis with ClustalX showed this human C. muris isolate
had a 100% nucleotide identity to that of a C. muris isolate
from a rock hyrax and a Bactrian camel (EMBL Accession no.
AF093498, AF093497), 98.8% identity to a C. muris “calf”
isolate (AF093496), 96.5% with C. serpentis (AF108866), and
only 87.8% identity to C. parvum human type (AF093489). C.
muris calf isolate (AF093496) has since been shown to be a
different species from C. muris (“mouse” type, Accession no.
AF093498 ) and has been given a new name, C. andersoni.
The phylogenetic tree showed topology similar to that already
published for Cryptosporidium, with C. parvum clustering in
one clade, and our patient’s sample and published sequences
of C. muris (rock hyrax isolate), C. andersoni (calf isolate),
and C. serpentis clustered in another group (Figure 2). 
Conclusions
Our study used genotypic analysis to confirm microscopic
detection of Cryptosporidium oocysts in fecal samples and
indicated that C. muris can indeed infect humans. Although
immunosuppression has been observed to produce an
increased susceptibility to cryptosporidiosis, the range of
Cryptosporidia that can cause human cryptosporidiosis is still
being elucidated (8,13,15). Lately, novel genotypes and non-C.
parvum species such as C. meleagridis, C. felis, and C. parvum
“dog” type have been identified not only in HIV-infected per-
sons but also in HIV-uninfected patients (7,9,10). Genotypic
analysis of Cryptosporidium organisms in fecal samples in the
United Kingdom showed the occurrence of C. meleagridis, C.
felis,  and C. parvum “dog” type in immunocompetent and
immunosuppressed persons (10,16). In another study in Peru,
C. felis, C. parvum “dog” type, and C. meleagridis were iden-
tified in children not infected with HIV. In that study, C.
meleagridis was as common as C. parvum “bovine” type; it
appeared to be a stable part of the enteric pathogen mix caus-
ing cryptosporidiosis, perhaps only being identified with cur-
rent definitive molecular methods (9). 
Figure 1. Cryptosporidium muris oocysts (under oil X 1,000), stained by
Kinyoun’s acid-fast staining.
Figure 2. Comparison of 18S rRNA gene sequences of Cryptosporid-
ium species. K33-C.muris from human patient (current paper Accession
no. AJ307669); C. m (muris) “rock hyrax” (Accession no. AF093498);
C.m. (muris) “calf” isolate (AF093496), now renamed C. andersoni; C.
serpentis (AF093499); C.p (parvum) “dog” (AF112576); C.p. “rhesus
monkey” (AF112569); C.p. “human” (AF093489); and C.p. “pig”
(AF115377). Numbers refer to the percentage of repeated analyses that
gave the same tree topology (bootstrap values). DISPATCHES
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C. muris infects the gastric glands of immunocompetent or
immunocompromised (nude and SCID) mice (17); however,
since our patient was co-infected with I. belli, the role of C.
muris in our patient’s gastroenteritis and its possible site of
infection in this patient are unclear. 
A report of possible asymptomatic C. muris infection in
healthy persons (11) and our finding of it in an immunosup-
pressed patient suggest that this may be yet another
Cryptosporidium species with a zoonotic potential. The range
of animal reservoir hosts in which C. muris has been identified
or experimentally transmitted adds to the importance of
Cryptosporidium species as a public health concern (3,4,15).
The current genotypic analyses are making it possible to make
more conclusive diagnoses and to speculate on possible
sources of infection (14-16). These techniques will need to be
applied more widely to identify and characterize isolates of
Cryptosporidium for more definitive epidemiologic mapping.
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